Scott Durbin - 23 Jun 2021 Form 4 Insider Report for VIVEVE MEDICAL, INC.

Role
Chief Executive Officer, Director
Signature
/s/ Jim Robbins, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
23 Jun 2021
Net transactions value
$0
Form type
4
Filing time
25 Jun 2021, 16:06:39 UTC
Next filing
17 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVE Incentive Stock Option (Right to Purchase) Award $0 +655,300 $0.000000 655,300 23 Jun 2021 Common Stock 655,300 $2.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the "Plan") and received 655,300 incentive stock options on June 23, 2021 (the "Grant Date"). The incentive stock options shall vest and become exercisable in 48 equal monthly installments from the Grant Date.